KPP Advisory Services LLC Decreases Position in CVS Health Corporation (NYSE:CVS)

KPP Advisory Services LLC reduced its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 58.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,965 shares of the pharmacy operator's stock after selling 4,156 shares during the period. KPP Advisory Services LLC's holdings in CVS Health were worth $201,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CVS. McIlrath & Eck LLC lifted its position in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after buying an additional 174 shares in the last quarter. Horizon Bancorp Inc. IN lifted its position in shares of CVS Health by 7.4% during the 1st quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock valued at $177,000 after buying an additional 180 shares in the last quarter. Coppell Advisory Solutions LLC lifted its position in shares of CVS Health by 17.3% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after buying an additional 189 shares in the last quarter. Strategic Investment Advisors MI lifted its position in shares of CVS Health by 2.3% in the first quarter. Strategic Investment Advisors MI now owns 8,466 shares of the pharmacy operator's stock valued at $574,000 after acquiring an additional 194 shares in the last quarter. Finally, EagleClaw Capital Managment LLC lifted its position in shares of CVS Health by 3.4% in the fourth quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock valued at $275,000 after acquiring an additional 200 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at CVS Health

In related news, Director Guy P. Sansone purchased 1,570 shares of the business's stock in a transaction on Thursday, June 5th. The shares were bought at an average cost of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director now owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.22% of the stock is owned by insiders.

CVS Health Stock Up 0.5%

Shares of CVS stock traded up $0.36 during trading hours on Friday, reaching $68.50. 5,937,044 shares of the company's stock were exchanged, compared to its average volume of 10,854,461. The stock's 50 day moving average is $64.86 and its 200-day moving average is $60.86. The company has a market cap of $86.66 billion, a price-to-earnings ratio of 16.35, a P/E/G ratio of 0.98 and a beta of 0.56. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The business's quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.31 earnings per share. Analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently commented on CVS. UBS Group boosted their price objective on CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a research report on Friday, May 2nd. Cowen restated a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Royal Bank Of Canada boosted their price objective on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Piper Sandler boosted their price objective on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. Finally, Robert W. Baird boosted their price objective on CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Two analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.